Sort
48,018 grants matching “immunotherapy”
Understanding and harnessing immune-modulatory effects of covalent KRASG12C inhibitors in KRASG12C-mutant non-small cell lung cancer
$370,575Ferdinandos Skoulidis · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Understanding and harnessing immune-modulatory effects of covalent KRASG12C inhibitors in KRASG12C-mutant non-small cell lung cancer
$370,575Ferdinandos Skoulidis · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Paradoxical roles of tumor lymphangiogenesis on tumor immunity and implications for immunotherapy - Resubmission 01
$370,575Melody A Swartz · University Of Chicago · R01 · FY2021 · CA
TROP2-Directed CAR-NK Cells for the Immunotherapy of Pancreatic Cancer
$370,575Rafet Basar · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Transcriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors
$370,575Timothy Anthony Yap · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Novel small molecule USP7 Inhibitors for p53 activation and cancer therapy
$370,575Wei Gu · Columbia University Health Sciences · R01 · FY2025 · CA
Dissecting the source and mechanisms of IL-17-mediated modulation of pancreatic tumorigenesis
$370,575Florencia McAllister · University Of Tx Md Anderson Can Ctr · R37 · FY2021 · CA
Transcriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors
$370,575Timothy Anthony Yap · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
CLL clonal evolution and the development of therapy-driven resistance
$370,572Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2017 · CA
Mechanism of self antigen-induced non-responsivesness in CD8 T cells
$370,564Matthew F Mescher · University Of Minnesota · P01 · FY2015 · AI
Recognition and Targeting of CNS Lymphoma by Tumor-Associated Macrophages
$370,554James Louis Rubenstein · University Of California, San Francisco · R01 · FY2016 · CA
Recognition and Targeting of CNS Lymphoma by Tumor-Associated Macrophages
$370,554James Louis Rubenstein · University Of California, San Francisco · R01 · FY2017 · CA
Recognition and Targeting of CNS Lymphoma by Tumor-Associated Macrophages
$370,554James Louis Rubenstein · University Of California, San Francisco · R01 · FY2015 · CA
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
$370,552Fernando Macian · Albert Einstein College Of Medicine · R01 · FY2019 · CA
Project 1: Immune Memory
$370,523Rafi Ahmed · Emory University · U19 · FY2022 · AI
T Cell Reagent Research for Monitoring T Cell in Food Allergy
$370,520Kari C. Nadeau · Stanford University · U01 · FY2018 · AI
Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer.
$370,513Tracy L McGaha · University Health Network · R01 · FY2025 · CA
Autoimmune vitiligo and tolerance in the immune response to a melanoma antigen
$370,513Victor H. Engelhard · University Of Virginia · R01 · FY2008 · AI
Skeletal survivorship and immune therapy: The effects of nivolumab on bone metabolism in renal cell carcinoma
$370,511Kendall Moseley · Johns Hopkins University · R21 · FY2019 · AR
Innate Immune Therapy for B-Cell Malignancies
$370,509John C Byrd · Ohio State University · P01 · FY2014 · CA
HSP 110 and its role in cancer therapy
$370,504John R. Subjeck · Roswell Park Cancer Institute Corp · R01 · FY2011 · CA
Combinatorial Targeting of Epigenomic and Microenvironmental Pathways to Suppress MAPK Inhibitor Resistance in Melanoma
$370,500Roger S Lo · University Of California Los Angeles · R01 · FY2020 · CA
Develop a Therapeutic Nano-vaccine against Head and Neck Cancer
$370,500Yu Leo Lei · University Of Michigan At Ann Arbor · R01 · FY2019 · DE
Develop a Therapeutic Nano-vaccine against Head and Neck Cancer
$370,500Yu Leo Lei · University Of Michigan At Ann Arbor · R01 · FY2021 · DE
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma
$370,500Andrew E Aplin · Thomas Jefferson University · R01 · FY2020 · CA